163 related articles for article (PubMed ID: 35022253)
1. Post BNT162b2 mRNA COVID-19 vaccination Henoch-Schӧnlein Pupura.
Wang SSY
Postgrad Med J; 2022 Dec; 98(1166):900-901. PubMed ID: 35022253
[No Abstract] [Full Text] [Related]
2. Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study.
Wong CKH; Lau KTK; Xiong X; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Chan EWY; Gao L; Cheng FWT; Tang SCW; Wong ICK
PLoS Med; 2022 Jun; 19(6):e1004018. PubMed ID: 35727759
[TBL] [Abstract][Full Text] [Related]
3. Why two doses of the BNT162b2 mRNA COVID-19 vaccine? A different strategy to speed up the vaccination process: single-dose of the BNT162b2 mRNA COVID-19 and other vaccines.
LA Vecchia C; Centanni S; Gerli AG
Panminerva Med; 2022 Mar; 64(1):131-132. PubMed ID: 33480519
[No Abstract] [Full Text] [Related]
4. Asymptomatic infection after BNT162b2 mRNA COVID-19 vaccination in multiple sclerosis patient.
Jakimovski D; Weinstock-Guttman B
Acta Neurol Belg; 2022 Apr; 122(2):565-566. PubMed ID: 34529258
[No Abstract] [Full Text] [Related]
5. Safety of Inactivated and mRNA COVID-19 Vaccination Among Patients Treated for Hypothyroidism: A Population-Based Cohort Study.
Xiong X; Wong CKH; Au ICH; Lai FTT; Li X; Wan EYF; Chui CSL; Chan EWY; Cheng FWT; Lau KTK; Lee CH; Woo YC; Lui DTW; Wong ICK
Thyroid; 2022 May; 32(5):505-514. PubMed ID: 35216517
[No Abstract] [Full Text] [Related]
6. Severe acute interstitial lung disease after BNT162b2 mRNA COVID-19 vaccination in a patient post HLA-haploidentical hematopoietic stem cell transplantation.
Ueno T; Ohta T; Sugio Y; Ohno Y; Uehara Y
Bone Marrow Transplant; 2022 May; 57(5):840-842. PubMed ID: 35273388
[No Abstract] [Full Text] [Related]
7. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
Beckley M; Olson AK; Portman MA
JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
[TBL] [Abstract][Full Text] [Related]
8. Prominent J Waves and Ventricular Fibrillation Caused by Myocarditis and Pericarditis After BNT162b2 mRNA COVID-19 Vaccination.
Uesako H; Fujikawa H; Hashimoto S; Wakabayashi T
Can J Cardiol; 2022 Jun; 38(6):844-847. PubMed ID: 35151782
[No Abstract] [Full Text] [Related]
9. Short-term Adverse Events After the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine in Adults 60 Years or Older.
Auster O; Finkel U; Dagan N; Barda N; Laufer A; Balicer RD; Ben-Shachar S
JAMA Netw Open; 2022 Apr; 5(4):e227657. PubMed ID: 35435973
[TBL] [Abstract][Full Text] [Related]
10. Herpes zoster following BNT162b2 mRNA COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series.
Furer V; Zisman D; Kibari A; Rimar D; Paran Y; Elkayam O
Rheumatology (Oxford); 2021 Oct; 60(SI):SI90-SI95. PubMed ID: 33848321
[TBL] [Abstract][Full Text] [Related]
11. Haematological changes and adverse events associated with BNT162b2 mRNA COVID-19 vaccine in patients receiving clozapine-Findings from an audit.
Lim S; Liew E; Leo A; Ng BT; Lee J
Acta Psychiatr Scand; 2022 Aug; 146(2):179-181. PubMed ID: 35582980
[No Abstract] [Full Text] [Related]
12. Erythema nodosum triggered by BNT162b2 mRNA COVID-19 vaccine.
Juddoo V; Juddoo S; Mégarbane B
Vaccine; 2022 Apr; 40(19):2650-2651. PubMed ID: 35365342
[No Abstract] [Full Text] [Related]
13. Risk of thyroid dysfunction associated with mRNA and inactivated COVID-19 vaccines: a population-based study of 2.3 million vaccine recipients.
Wong CKH; Lui DTW; Xiong X; Chui CSL; Lai FTT; Li X; Wan EYF; Cheung CL; Lee CH; Woo YC; Au ICH; Chung MSH; Cheng FWT; Tan KCB; Wong ICK
BMC Med; 2022 Oct; 20(1):339. PubMed ID: 36229814
[TBL] [Abstract][Full Text] [Related]
14. Management of BNT162b2 mRNA COVID-19 vaccine in children aged 5-11 years with allergies, asthma, and immunodeficiency: consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP).
Novembre E; Tosca M; Caffarelli C; Calvani M; Cardinale F; Castagnoli R; Chiappini E; Cravidi C; Del Giudice MM; Duse M; Licari A; Manti S; Martelli A; Ricci G; Pingitore G; Marseglia GL
Ital J Pediatr; 2022 May; 48(1):76. PubMed ID: 35578294
[TBL] [Abstract][Full Text] [Related]
15. Leukocytoclastic vasculitis in possible relation to the BNT162b2 mRNA COVID-19 vaccine.
Carrillo-Garcia P; Sánchez-Osorio L; Gómez-Pavón J
J Am Geriatr Soc; 2022 Apr; 70(4):971-973. PubMed ID: 35099065
[No Abstract] [Full Text] [Related]
16. Eosinophilic cellulitis in response to BNT162b2 COVID-19 vaccination.
Ikediobi O; Eichenfield DZ; Barrio VR
Pediatr Dermatol; 2022 Sep; 39(5):823-824. PubMed ID: 35522122
[TBL] [Abstract][Full Text] [Related]
17. Oral lichen planus arising after BNT162b2 mRNA COVID-19 vaccine: report of 2 cases.
Raccampo L; Sembronio S; Tel A; Cacitti V; Robiony M
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Sep; 134(3):e54-e57. PubMed ID: 35851250
[TBL] [Abstract][Full Text] [Related]
18. Safety Profile and Low Risk of Disease Relapse After BNT162b2 mRNA SARS-CoV-2 Vaccination in Patients With Rare Rheumatic Diseases.
Fornaro M; Venerito V; Iannone F; Cacciapaglia F
J Rheumatol; 2022 Mar; 49(3):334-335. PubMed ID: 35033998
[No Abstract] [Full Text] [Related]
19. Kikuchi-Fujimoto disease associated with hemophagocytic lymphohistiocytosis following the BNT162b2 mRNA COVID-19 vaccination.
Caocci G; Fanni D; Porru M; Greco M; Nemolato S; Firinu D; Faa G; Scuteri A; La Nasa G
Haematologica; 2022 May; 107(5):1222-1225. PubMed ID: 34965702
[No Abstract] [Full Text] [Related]
20. Acute Myocarditis after mRNA COVID-19 Vaccine: A CorrespondenceReplyAcute Myocarditis Following mRNA COVID-19 VaccineMyocarditis after BNT162b2 mRNA Vaccine Against Covid-19 in IsraelMyocarditis after Covid-19 Vaccination in a Large Health Care OrganizationReceipt of mRNA Vaccine against Covid-19 and Myocarditis.
Mungmunpuntipantip R; Wiwanitkit V
Arq Bras Cardiol; 2022 Dec; 119(6):1006-1007. PubMed ID: 36542000
[No Abstract] [Full Text] [Related]
[Next] [New Search]
